{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:23:00Z","timestamp":1790504580142,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T00:00:00Z","timestamp":1544486400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"crossref","award":["BEX \/ 88881.132606\/2016-01 PDSE"],"award-info":[{"award-number":["BEX \/ 88881.132606\/2016-01 PDSE"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008115","name":"School of Dentistry, University of Michigan","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100008115","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["P30 CA046592"],"award-info":[{"award-number":["P30 CA046592"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s13402-018-0416-2","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T19:01:09Z","timestamp":1544554869000},"page":"143-155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Interfering with bromodomain epigenome readers as therapeutic option in mucoepidermoid carcinoma"],"prefix":"10.1007","volume":"42","author":[{"given":"Renata L.","family":"Markman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana P.","family":"Webber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos H. V.","family":"Nascimento Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo A.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo A.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio A.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgilio","family":"Zanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoela D.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane H.","family":"Squarize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5358-612X","authenticated-orcid":false,"given":"Rogerio M.","family":"Castilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,11]]},"reference":[{"key":"416_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1590\/S0041-87812002000600005","volume":"57","author":"PA Vargas","year":"2002","unstructured":"P.A. Vargas, R. Gerhard, V.J. Araujo Filho, I.V. de Castro, Salivary gland tumors in a Brazilian population: A retrospective study of 124 cases. Rev. Hosp. Clin. Fac. Med. Sao Paulo 57, 271\u2013276 (2002)","journal-title":"Rev. Hosp. Clin. Fac. Med. Sao Paulo"},{"key":"416_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12105-009-0139-9","volume":"3","author":"FA Oliveira de","year":"2009","unstructured":"F.A. de Oliveira, E.C. Duarte, C.T. Taveira, A.A. Maximo, E.C. de Aquino, C. Alencar Rde, E.F. Vencio, Salivary gland tumor: a review of 599 cases in a Brazilian population. Head Neck Pathol. 3, 271\u2013275 (2009)","journal-title":"Head Neck Pathol."},{"key":"416_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.oooo.2012.04.008","volume":"114","author":"FP Fonseca","year":"2012","unstructured":"F.P. Fonseca, V. Carvalho Mde, O.P. de Almeida, A.L. Rangel, M.C. Takizawa, A.G. Bueno, P.A. Vargas, Clinicopathologic analysis of 493 cases of salivary gland tumors in a southern Brazilian population. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 114, 230\u2013239 (2012)","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"416_CR4","unstructured":"E.S. Choi, S. Oh, B. Jang, H.J. Yu, J.A. Shin, N.P. Cho, I.H. Yang, D.H. Won, H.J. Kwon, S.D. Hong, S.D. Cho, Silymarin and its active component silibinin act as novel therapeutic alternatives for salivary gland cancer by targeting the ERK1\/2-Bim signaling cascade. Cell Oncol. 40, 235\u2013246 (2017)"},{"key":"416_CR5","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.anndiagpath.2013.05.008","volume":"17","author":"N Saghravanian","year":"2013","unstructured":"N. Saghravanian, N. Ghazi, M. Saba, Clinicopathologic evaluation of salivary gland neoplasms: a 38-year retrospective study in Iran. Ann. Diagn. Pathol. 17, 522\u2013525 (2013)","journal-title":"Ann. Diagn. Pathol."},{"key":"416_CR6","doi-asserted-by":"crossref","unstructured":"J.H. Mikesch, W. Hartmann, L. Angenendt, O. Huber, C. Schliemann, M.F. Arteaga, E. Wardelmann, C. Rudack, W.E. Berdel, M. Stenner and I. Grunewald, AAA+ ATPases Reptin and Pontin as potential diagnostic and prognostic biomarkers in salivary gland cancer - a short report. Cell Oncol. 41,\u00a0455\u2013462 (2018)","DOI":"10.1007\/s13402-018-0382-8"},{"key":"416_CR7","unstructured":"L. Barnes, Universit\u00e4ts-Spital Zurich. Dept. Pathologie., International Academy of Pathology., World Health Organization. and International Agency for Research on Cancer., Pathology and genetics of head and neck tumours, (IARC Press, Lyon, 2007)"},{"key":"416_CR8","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/1097-0142(19821201)50:11<2261::AID-CNCR2820501105>3.0.CO;2-E","volume":"50","author":"MR Posner","year":"1982","unstructured":"M.R. Posner, T.J. Ervin, R.R. Weichselbaum, R.L. Fabian, D. Miller, Chemotherapy of advanced salivary gland neoplasms. Cancer 50, 2261\u20132264 (1982)","journal-title":"Cancer"},{"key":"416_CR9","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/1752-1947-2-320","volume":"2","author":"S Grisanti","year":"2008","unstructured":"S. Grisanti, V. Amoroso, M. Buglione, A. Rosati, R. Gatta, C. Pizzocaro, V.D. Ferrari, G. Marini, Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. J. Med. Case Rep. 2, 320 (2008)","journal-title":"J. Med. Case Rep."},{"key":"416_CR10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.critrevonc.2014.02.002","volume":"91","author":"T Cerda","year":"2014","unstructured":"T. Cerda, X.S. Sun, S. Vignot, P.Y. Marcy, B. Baujat, A.C. Baglin, A.M. Ali, S. Testelin, E. Reyt, F. Janot, J. Thariat, A rationale for chemoradiation (vs radiotherapy) in salivary gland cancers? On behalf of the REFCOR (French rare head and neck cancer network). Crit. Rev. Oncol. Hematol. 91, 142\u2013158 (2014)","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"416_CR11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00405-014-3053-z","volume":"272","author":"A Coca-Pelaz","year":"2015","unstructured":"A. Coca-Pelaz, J.P. Rodrigo, A. Triantafyllou, J.L. Hunt, A. Rinaldo, P. Strojan, M. Haigentz Jr., W.M. Mendenhall, R.P. Takes, V. Vander Poorten, A. Ferlito, Salivary mucoepidermoid carcinoma revisited. Eur. Arch. Otorhinolaryngol. 272, 799\u2013819 (2015)","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"416_CR12","doi-asserted-by":"crossref","unstructured":"R.M. Castilho, C.H. Squarize, L.O. Almeida, Epigenetic modifications and head and neck Cancer: Implications for tumor progression and resistance to therapy. Int J Mol Sci. 18 E15063 (2017)","DOI":"10.3390\/ijms18071506"},{"key":"416_CR13","unstructured":"M.S. Gilardini Montani, M. Granato, C. Santoni, P. Del Porto, N. Merendino, G. D'Orazi, A. Faggioni, M. Cirone, Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells. Cell Oncol. 40, 167\u2013180 (2017)"},{"key":"416_CR14","unstructured":"M. Staberg, S.R. Michaelsen, R.D. Rasmussen, M. Villingshoj, H.S. Poulsen, P. Hamerlik, Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine. Cell Oncol. 40, 21\u201332 (2017)"},{"key":"416_CR15","doi-asserted-by":"publisher","first-page":"6264","DOI":"10.1158\/0008-5472.CAN-13-0122-T","volume":"73","author":"MF Segura","year":"2013","unstructured":"M.F. Segura, B. Fontanals-Cirera, A. Gaziel-Sovran, M.V. Guijarro, D. Hanniford, G. Zhang, P. Gonzalez-Gomez, M. Morante, L. Jubierre, W. Zhang, F. Darvishian, M. Ohlmeyer, I. Osman, M.M. Zhou, E. Hernando, BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy. Cancer Res. 73, 6264\u20136276 (2013)","journal-title":"Cancer Res."},{"key":"416_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/15592294.2016.1265710","volume":"12","author":"M Perez-Salvia","year":"2017","unstructured":"M. Perez-Salvia, M. Esteller, Bromodomain inhibitors and cancer therapy: From structures to applications. Epigenetics 12, 323\u2013339 (2017)","journal-title":"Epigenetics"},{"key":"416_CR17","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/S0002-9440(10)63049-0","volume":"159","author":"CA French","year":"2001","unstructured":"C.A. French, I. Miyoshi, J.C. Aster, I. Kubonishi, T.G. Kroll, P. Dal Cin, S.O. Vargas, A.R. Perez-Atayde, J.A. Fletcher, BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19). Am. J. Pathol. 159, 1987\u20131992 (2001)","journal-title":"Am. J. Pathol."},{"key":"416_CR18","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1128\/MCB.22.11.3794-3802.2002","volume":"22","author":"D Houzelstein","year":"2002","unstructured":"D. Houzelstein, S.L. Bullock, D.E. Lynch, E.F. Grigorieva, V.A. Wilson, R.S. Beddington, Growth and early postimplantation defects in mice deficient for the bromodomain-containing protein Brd4. Mol. Cell. Biol. 22, 3794\u20133802 (2002)","journal-title":"Mol. Cell. Biol."},{"key":"416_CR19","doi-asserted-by":"publisher","first-page":"9040","DOI":"10.1074\/jbc.M707603200","volume":"283","author":"K Mochizuki","year":"2008","unstructured":"K. Mochizuki, A. Nishiyama, M.K. Jang, A. Dey, A. Ghosh, T. Tamura, H. Natsume, H. Yao, K. Ozato, The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase. J. Biol. Chem. 283, 9040\u20139048 (2008)","journal-title":"J. Biol. Chem."},{"key":"416_CR20","doi-asserted-by":"publisher","first-page":"73032","DOI":"10.18632\/oncotarget.12195","volume":"7","author":"VP Wagner","year":"2016","unstructured":"V.P. Wagner, M.A. Martins, M.D. Martins, K.A. Warner, L.P. Webber, C.H. Squarize, J.E. Nor, R.M. Castilho, Overcoming adaptive resistance in mucoepidermoid carcinoma through inhibition of the IKK-beta\/IkappaBalpha\/NFkappaB axis. Oncotarget 7, 73032\u201373044 (2016)","journal-title":"Oncotarget"},{"key":"416_CR21","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/nprot.2006.339","volume":"1","author":"NA Franken","year":"2006","unstructured":"N.A. Franken, H.M. Rodermond, J. Stap, J. Haveman, C. van Bree, Clonogenic assay of cells in vitro. Nat. Protoc. 1, 2315\u20132319 (2006)","journal-title":"Nat. Protoc."},{"key":"416_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/0022034515611876","volume":"95","author":"MD Martins","year":"2016","unstructured":"M.D. Martins, Y. Jiao, L. Larsson, L.O. Almeida, C. Garaicoa-Pazmino, J.M. Le, C.H. Squarize, N. Inohara, W.V. Giannobile, R.M. Castilho, Epigenetic modifications of histones in periodontal disease. J. Dent. Res. 95, 215\u2013222 (2016)","journal-title":"J. Dent. Res."},{"key":"416_CR23","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/nature09589","volume":"468","author":"E Nicodeme","year":"2010","unstructured":"E. Nicodeme, K.L. Jeffrey, U. Schaefer, S. Beinke, S. Dewell, C.W. Chung, R. Chandwani, I. Marazzi, P. Wilson, H. Coste, J. White, J. Kirilovsky, C.M. Rice, J.M. Lora, R.K. Prinjha, K. Lee, A. Tarakhovsky, Suppression of inflammation by a synthetic histone mimic. Nature 468, 1119\u20131123 (2010)","journal-title":"Nature"},{"key":"416_CR24","doi-asserted-by":"publisher","first-page":"7501","DOI":"10.1021\/jm401088k","volume":"56","author":"O Mirguet","year":"2013","unstructured":"O. Mirguet, R. Gosmini, J. Toum, C.A. Clement, M. Barnathan, J.M. Brusq, J.E. Mordaunt, R.M. Grimes, M. Crowe, O. Pineau, M. Ajakane, A. Daugan, P. Jeffrey, L. Cutler, A.C. Haynes, N.N. Smithers, C.W. Chung, P. Bamborough, I.J. Uings, A. Lewis, J. Witherington, N. Parr, R.K. Prinjha, E. Nicodeme, Discovery of epigenetic regulator I-BET762: Lead optimization to afford a clinical candidate inhibitor of the BET bromodomains. J. Med. Chem. 56, 7501\u20137515 (2013)","journal-title":"J. Med. Chem."},{"key":"416_CR25","doi-asserted-by":"publisher","first-page":"8403","DOI":"10.1093\/nar\/gkx561","volume":"45","author":"S Wang","year":"2017","unstructured":"S. Wang, A.M. Pike, S.S. Lee, M.A. Strong, C.J. Connelly, C.W. Greider, BRD4 inhibitors block telomere elongation. Nucleic Acids Res. 45, 8403\u20138410 (2017)","journal-title":"Nucleic Acids Res."},{"key":"416_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.scr.2017.04.003","volume":"21","author":"LO Almeida","year":"2017","unstructured":"L.O. Almeida, D.M. Guimaraes, M.D. Martins, M.A.T. Martins, K.A. Warner, J.E. Nor, R.M. Castilho, C.H. Squarize, Unlocking the chromatin of adenoid cystic carcinomas using HDAC inhibitors sensitize cancer stem cells to cisplatin and induces tumor senescence. Stem Cell Res. 21, 94\u2013105 (2017)","journal-title":"Stem Cell Res."},{"key":"416_CR27","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1111\/febs.13746","volume":"283","author":"A Newbold","year":"2016","unstructured":"A. Newbold, K.J. Falkenberg, H.M. Prince, R.W. Johnstone, How do tumor cells respond to HDAC inhibition? FEBS J. 283, 4032\u20134046 (2016)","journal-title":"FEBS J."},{"key":"416_CR28","doi-asserted-by":"crossref","first-page":"42447","DOI":"10.18632\/oncotarget.9884","volume":"7","author":"DM Guimaraes","year":"2016","unstructured":"D.M. Guimaraes, L.O. Almeida, M.D. Martins, K.A. Warner, A.R. Silva, P.A. Vargas, F.D. Nunes, C.H. Squarize, J.E. Nor, R.M. Castilho, Sensitizing mucoepidermoid carcinomas to chemotherapy by targeted disruption of cancer stem cells. Oncotarget 7, 42447\u201342460 (2016)","journal-title":"Oncotarget"},{"key":"416_CR29","doi-asserted-by":"crossref","first-page":"26633","DOI":"10.18632\/oncotarget.5782","volume":"6","author":"A Adams","year":"2015","unstructured":"A. Adams, K. Warner, A.T. Pearson, Z. Zhang, H.S. Kim, D. Mochizuki, G. Basura, J. Helman, A. Mantesso, R.M. Castilho, M.S. Wicha, J.E. Nor, ALDH\/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas. Oncotarget 6, 26633\u201326650 (2015)","journal-title":"Oncotarget"},{"key":"416_CR30","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1038\/s41598-018-20345-w","volume":"8","author":"VP Wagner","year":"2018","unstructured":"V.P. Wagner, M.D. Martins, M.A.T. Martins, L.O. Almeida, K.A. Warner, J.E. Nor, C.H. Squarize, R.M. Castilho, Targeting histone deacetylase and NFkappaB signaling as a novel therapy for Mucoepidermoid carcinomas. Sci. Rep. 8, 2065 (2018)","journal-title":"Sci. Rep."},{"key":"416_CR31","unstructured":"M. Granic, P. Suton, D. Mueller, I. Cvrljevic, I. Luksic, Prognostic factors in head and neck mucoepidermoid carcinoma: experience at a single institution based on 64 consecutive patients over a 28-year period. Int J Oral Maxillofac Surg. 47, 283-288 (2018)"},{"key":"416_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.oraloncology.2017.02.025","volume":"68","author":"AC Birkeland","year":"2017","unstructured":"A.C. Birkeland, S.K. Foltin, N.L. Michmerhuizen, R.C. Hoesli, A.J. Rosko, S. Byrd, M. Yanik, J.E. Nor, C.R. Bradford, M.E. Prince, T.E. Carey, J.B. McHugh, M.E. Spector, J.C. Brenner, Correlation of Crtc1\/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma. Oral Oncol. 68, 5\u20138 (2017)","journal-title":"Oral Oncol."},{"key":"416_CR33","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nsmb.3228","volume":"23","author":"BN Devaiah","year":"2016","unstructured":"B.N. Devaiah, C. Case-Borden, A. Gegonne, C.H. Hsu, Q. Chen, D. Meerzaman, A. Dey, K. Ozato, D.S. Singer, BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin. Nat. Struct. Mol. Biol. 23, 540\u2013548 (2016)","journal-title":"Nat. Struct. Mol. Biol."},{"key":"416_CR34","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1159\/000472407","volume":"41","author":"X Wu","year":"2017","unstructured":"X. Wu, D. Liu, X. Gao, F. Xie, D. Tao, X. Xiao, L. Wang, G. Jiang, F. Zeng, Inhibition of BRD4 suppresses cell proliferation and induces apoptosis in renal cell carcinoma. Cell. Physiol. Biochem. 41, 1947\u20131956 (2017)","journal-title":"Cell. Physiol. Biochem."},{"key":"416_CR35","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature10334","volume":"478","author":"J Zuber","year":"2011","unstructured":"J. Zuber, J. Shi, E. Wang, A.R. Rappaport, H. Herrmann, E.A. Sison, D. Magoon, J. Qi, K. Blatt, M. Wunderlich, M.J. Taylor, C. Johns, A. Chicas, J.C. Mulloy, S.C. Kogan, P. Brown, P. Valent, J.E. Bradner, S.W. Lowe, C.R. Vakoc, RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478, 524\u2013528 (2011)","journal-title":"Nature"},{"key":"416_CR36","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1182\/blood-2013-01-478420","volume":"123","author":"A Chaidos","year":"2014","unstructured":"A. Chaidos, V. Caputo, K. Gouvedenou, B. Liu, I. Marigo, M.S. Chaudhry, A. Rotolo, D.F. Tough, N.N. Smithers, A.K. Bassil, T.D. Chapman, N.R. Harker, O. Barbash, P. Tummino, N. Al-Mahdi, A.C. Haynes, L. Cutler, B. Le, A. Rahemtulla, I. Roberts, M. Kleijnen, J.J. Witherington, N.J. Parr, R.K. Prinjha, A. Karadimitris, Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762. Blood 123, 697\u2013705 (2014)","journal-title":"Blood"},{"key":"416_CR37","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","volume":"146","author":"JE Delmore","year":"2011","unstructured":"J.E. Delmore, G.C. Issa, M.E. Lemieux, P.B. Rahl, J. Shi, H.M. Jacobs, E. Kastritis, T. Gilpatrick, R.M. Paranal, J. Qi, M. Chesi, A.C. Schinzel, M.R. McKeown, T.P. Heffernan, C.R. Vakoc, P.L. Bergsagel, I.M. Ghobrial, P.G. Richardson, R.A. Young, W.C. Hahn, K.C. Anderson, A.L. Kung, J.E. Bradner, C.S. Mitsiades, BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146, 904\u2013917 (2011)","journal-title":"Cell"},{"key":"416_CR38","doi-asserted-by":"publisher","unstructured":"S.B. Baylin, P.A. Jones, Epigenetic determinants of Cancer. Cold Spring Harb Perspect Biol. 8(9) (2016). https:\/\/doi.org\/10.1101\/cshperspect.a019505","DOI":"10.1101\/cshperspect.a019505"},{"key":"416_CR39","doi-asserted-by":"publisher","first-page":"6320","DOI":"10.1158\/0008-5472.CAN-16-0854","volume":"76","author":"Y Yokoyama","year":"2016","unstructured":"Y. Yokoyama, H. Zhu, J.H. Lee, A.V. Kossenkov, S.Y. Wu, J.M. Wickramasinghe, X. Yin, K.C. Palozola, A. Gardini, L.C. Showe, K.S. Zaret, Q. Liu, D. Speicher, J.R. Conejo-Garcia, J.E. Bradner, Z. Zhang, A.K. Sood, T. Ordog, B.G. Bitler, R. Zhang, BET inhibitors suppress ALDH activity by targeting ALDH1A1 super-enhancer in ovarian Cancer. Cancer Res. 76, 6320\u20136330 (2016)","journal-title":"Cancer Res."},{"key":"416_CR40","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1158\/2159-8290.CD-16-0217","volume":"6","author":"N Tasdemir","year":"2016","unstructured":"N. Tasdemir, A. Banito, J.S. Roe, D. Alonso-Curbelo, M. Camiolo, D.F. Tschaharganeh, C.H. Huang, O. Aksoy, J.E. Bolden, C.C. Chen, M. Fennell, V. Thapar, A. Chicas, C.R. Vakoc, S.W. Lowe, BRD4 connects enhancer remodeling to senescence immune surveillance. Cancer Discov. 6, 612\u2013629 (2016)","journal-title":"Cancer Discov."},{"key":"416_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cell.2007.07.003","volume":"130","author":"M Collado","year":"2007","unstructured":"M. Collado, M.A. Blasco, M. Serrano, Cellular senescence in cancer and aging. Cell 130, 223\u2013233 (2007)","journal-title":"Cell"},{"key":"416_CR42","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.stem.2009.06.017","volume":"5","author":"RM Castilho","year":"2009","unstructured":"R.M. Castilho, C.H. Squarize, L.A. Chodosh, B.O. Williams, J.S. Gutkind, mTOR mediates Wnt-induced epidermal stem cell exhaustion and aging. Cell Stem Cell 5, 279\u2013289 (2009)","journal-title":"Cell Stem Cell"},{"key":"416_CR43","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1126\/science.1143578","volume":"317","author":"H Liu","year":"2007","unstructured":"H. Liu, M.M. Fergusson, R.M. Castilho, J. Liu, L. Cao, J. Chen, D. Malide, I.I. Rovira, D. Schimel, C.J. Kuo, J.S. Gutkind, P.M. Hwang, T. Finkel, Augmented Wnt signaling in a mammalian model of accelerated aging. Science 317, 803\u2013806 (2007)","journal-title":"Science"},{"key":"416_CR44","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrm2233","volume":"8","author":"J Campisi","year":"2007","unstructured":"J. Campisi, F. d\u2019Adda di Fagagna, Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8, 729\u2013740 (2007)","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"416_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"D. Hanahan, R.A. Weinberg, The hallmarks of cancer. Cell 100, 57\u201370 (2000)","journal-title":"Cell"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-018-0416-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13402-018-0416-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-018-0416-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T09:47:54Z","timestamp":1605606474000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13402-018-0416-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,11]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["416"],"URL":"https:\/\/doi.org\/10.1007\/s13402-018-0416-2","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,11]]},"assertion":[{"value":"19 November 2018","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}